+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 16Years +
All Genders
ID06513065

Comparing Low-Dose Versus High-Dose Mitomycin C During Heated Chemotherapy After Surgery for Pseudomyxoma Peritonei

Led by University of Southampton · Updated on 2026-02-19

176

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to improve treatment for patients diagnosed with Pseudomyxoma Peritonei PMP, a rare cancer that typically begins in the appendix and spreads within the abdomen. The study compares two doses of heated chemotherapy given during surgery called Hyperthermic Intraperitoneal Chemotherapy HIPEC to determine which dose better prevents cancer recurrence and balances risks. The trial uses a phase III randomized, single-blinded design to evaluate whether a lower dose of mitomycin C is as effective as a higher dose in treating PMP. Participants receive cytoreductive surgery followed by HIPEC with mitomycin C in one of two doses 10 mgm2 given as a single dose over 60 minutes or 35 mgm2 given in fractionated doses over 90 minutes. Both doses are currently used worldwide, but this trial seeks to directly compare their outcomes. Alongside treatment, blood and tissue samples will be collected for genetic analysis to explore disease biology and potential targeted therapies. During the study, participants will be monitored for disease-free survival over 24 months, with regular assessments including quality of life questionnaires, healthcare resource use, and adverse event tracking. The trial also evaluates healthcare costs and quality-adjusted life years. This comprehensive follow-up aims to provide insight into treatment safety, patient well-being, and long-term outcomes after HIPEC treatment for PMP.

CONDITIONS

Brief Title

Study to Evaluate the Non-inferiority of Low-dose HIPEC Versus High-dose HIPEC in the Treatment of PMP (HIPEC-PMP)

Research Team

C

Chris Wignall

K

Karen Martin

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here